Better Therapeutics, Inc. (BTTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
Better Therapeutics Market Cap
Better Therapeutics has a market cap or net worth of $55.00 as of March 9, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
55.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 17, 2021, Better Therapeutics's market cap has decreased from 66.05M to 55.00, a decrease of -100.00%. That is a compound annual growth rate of -94.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 55.00 | -98.99% |
| Dec 31, 2025 | 5.45K | - |
| Dec 31, 2024 | 5.45K | -99.94% |
| Dec 29, 2023 | 9.24M | -64.77% |
| Dec 30, 2022 | 26.24M | -76.09% |
| Dec 31, 2021 | 109.74M | 66.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |
| Genocea Biosciences | 59.00 |
| Arno Therapeutics | 49.00 |
| Athersys | 62.00 |
| Core One Labs | 47.00 |
| Mymetics | 46.00 |
| Gelesis Holdings | 73.00 |